Patents by Inventor Sanjay Khandekar

Sanjay Khandekar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Treatment for Cancer
    Publication number: 20240009307
    Abstract: Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory drug (e.g. pomalidomide or lenalidomide). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).
    Type: Application
    Filed: August 22, 2023
    Publication date: January 11, 2024
    Applicant: GlaxoSmithKline Intellectual Property Developement Limited
    Inventors: Sanjay KHANDEKAR, Patrick MAYES, Joanna OPALINSKA
  • COMBINATION TREATMENT FOR CANCER WITH ANTI-BCMA BINDING PROTEIN AND PROTEOSOME INHIBITOR
    Publication number: 20230019140
    Abstract: Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and a proteasome inhibitor (e.g. bortezomib). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).
    Type: Application
    Filed: June 22, 2022
    Publication date: January 19, 2023
    Inventors: Sanjay KHANDEKAR, Patrick MAYES, Joanna OPALINSKA
  • COMBINATION TREATMENT FOR CANCER
    Publication number: 20220411512
    Abstract: Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory agent (e.g. an agent directed to ICOS or an anti-CD38 antigen binding protein).
    Type: Application
    Filed: August 26, 2022
    Publication date: December 29, 2022
    Inventors: Axel HOOS, Sanjay KHANDEKAR, Patrick MAYES, Joanna OPALINSKA
  • Combination treatment for cancer with anti-BCMA binding protein and proteosome inhibitor
    Patent number: 11401334
    Abstract: Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and a proteasome inhibitor (e.g. bortezomib). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: August 2, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Sanjay Khandekar, Patrick Mayes, Joanna Opalinska
  • COMBINATION TREATMENT FOR CANCER
    Publication number: 20200270354
    Abstract: Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and a proteasome inhibitor (e.g. bortezomib). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).
    Type: Application
    Filed: September 12, 2018
    Publication date: August 27, 2020
    Inventors: Sanjay KHANDEKAR, Patrick MAYES, Joanna OPALINSKA
  • COMBINATION TREATMENT FOR CANCER
    Publication number: 20200254093
    Abstract: Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory drug (e.g. pomalidomide or lenalidomide). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).
    Type: Application
    Filed: September 12, 2018
    Publication date: August 13, 2020
    Inventors: Sanjay KHANDEKAR, Patrick MAYES, Joanna OPALINSKA
  • COMBINATION TREATMENT FOR CANCER
    Publication number: 20200255526
    Abstract: Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and an immunomodulatory agent (e.g. an agent directed to ICOS or an anti-CD38 antigen binding protein).
    Type: Application
    Filed: September 12, 2018
    Publication date: August 13, 2020
    Inventors: Axel HOOS, Sanjay KHANDEKAR, Patrick MAYES, Joanna OPALINSKA
  • Methods for identifying enzyme inhibitors and protein kinases
    Publication number: 20060234327
    Abstract: The present invention provides methods for identifying compounds that inhibit kinases. In addition, methods for profiling protein kinases are also provided. In addition, methods for determining the mode of action of kinase inhibitors are also provided.
    Type: Application
    Filed: March 17, 2004
    Publication date: October 19, 2006
    Inventors: Harold Bramson, George Glover, Sanjay Khandekar, Steven Ratcliffe